Adintrevimab

A4DAB006 | Infectious diseases | Phase-II/III
SARS-CoV-2 Spike
G1 / IgG1
Adagio Therapeutics
Phase-II/III
Whole mAb
ADG-20 ADG20
—
IMGT PubChem (443566421) PubChem (461565701) PubChem (472423467) PubChem (476262754) PubChem (476269366) PubChem (513906932) Thera-SAbDab YAbS
Avg A4D Score
-0.6308
Score Range
-0.63 to -0.63
Structures
2
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity

Associated Structural Profiles Level 2

Structure ID Source PDB Seq. Identity Avg. A4D Score pH (Min Agg.) pH (Max Agg.) Score CDR Score non-CDR
A4DAB006_7u2d_H_L 7u2d 99% -0.6331 6.5 9.0 -0.2532 -0.6905
A4DAB006_7u2e_H_L 7u2e 97% -0.6285 6.0 9.0 -0.2666 -0.6832